ISTA Pharmaceuticals, Inc. (ISTA) announced that financial guidance for the full year 2010, projecting net revenue of about $147 to $165 million.
In addition, ISTA anticipates reporting its first profitable year in 2010, with earnings per share for the full year expected to be at least $0.02, excluding any mark-to-market adjustments relating to warrants.
On average, three analysts polled by Thomson Reuters currently expect the company to earn $0.16 per share, on revenues of $147.90 million for fiscal 2010. Analysts estimates typically exclude special items.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.